董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Richard J. Mark Director 69 29.70万美元 未持股 2025-11-21
Richard Fisher Director 76 28.66万美元 未持股 2025-11-21
Cecil D. Haney Director 69 未披露 未持股 2025-11-21
Nadja Y. West Director 63 27.23万美元 未持股 2025-11-21
Meghan M. FitzGerald Director 54 29.20万美元 未持股 2025-11-21
Saumya Sutaria Director,Chairman and Chief Executive Officer 52 858.07万美元 未持股 2025-11-21
James L. Bierman Director 72 29.45万美元 未持股 2025-11-21
Roy Blunt Director 75 未披露 未持股 2025-11-21
Vineeta Agarwala Director 38 未披露 未持股 2025-11-21
Christopher S. Lynch Director 67 28.41万美元 未持股 2025-11-21
J. Robert Kerrey Lead Director 81 49.33万美元 未持股 2025-11-21
Tammy Romo Director 62 31.11万美元 未持股 2025-11-21

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Sun Park Executive Vice President and Chief Financial Officer 49 未披露 未持股 2025-11-21
Saumya Sutaria Director,Chairman and Chief Executive Officer 52 858.07万美元 未持股 2025-11-21
Paola M. Arbour Executive Vice President and Chief Information Officer 61 209.59万美元 未持股 2025-11-21
Thomas W. Arnst Executive Vice President, Chief Administrative Officer,General Counsel and Corporate Secretary 62 未披露 未持股 2025-11-21
Lisa Y. Foo Executive Vice President, Commercial Operations and Chief Operating Officer 34 未披露 未持股 2025-11-21

董事简历

中英对照 |  中文 |  英文
Richard J. Mark

Richard J. Mark,2002年加入Ameren Services。2005年,他当选为Ameren Missouri的客户运营高级副总裁。2012年,他放弃了 Ameren Missouri的职务,当选为 Ameren Illinois的董事长、总裁。


Richard J. Mark,career experience includes serving as Chairman and President of Ameren Illinois Company, an electric and gas regulated utility and wholly - owned subsidiary of Ameren Corporation, from 2012 until 2022. He joined Ameren in 2002 as Vice President of Customer Services and held a series of increasingly responsible management positions, including Senior Vice President, Customer Operations of Ameren Missouri where he oversaw electric and gas operations. Before joining Ameren, he was with Ancilia Systems Inc. where he served as President and Chief Executive Officer of St. Mary's Hospital in East St. Louis, Illinois. He is an NACD Board Leadership Fellow and a director of the Abraham Lincoln Presidential Library Foundation. He is a director of Tenet Healthcare Corporation and a former director of Ameren Illinois Company.
Richard J. Mark,2002年加入Ameren Services。2005年,他当选为Ameren Missouri的客户运营高级副总裁。2012年,他放弃了 Ameren Missouri的职务,当选为 Ameren Illinois的董事长、总裁。
Richard J. Mark,career experience includes serving as Chairman and President of Ameren Illinois Company, an electric and gas regulated utility and wholly - owned subsidiary of Ameren Corporation, from 2012 until 2022. He joined Ameren in 2002 as Vice President of Customer Services and held a series of increasingly responsible management positions, including Senior Vice President, Customer Operations of Ameren Missouri where he oversaw electric and gas operations. Before joining Ameren, he was with Ancilia Systems Inc. where he served as President and Chief Executive Officer of St. Mary's Hospital in East St. Louis, Illinois. He is an NACD Board Leadership Fellow and a director of the Abraham Lincoln Presidential Library Foundation. He is a director of Tenet Healthcare Corporation and a former director of Ameren Illinois Company.
Richard Fisher

Richard Fisher从2005年到2015年担任达拉斯联邦储备银行的总裁兼首席执行官。任职期间,他曾担任联邦公开市场政策委员会成员,联邦储备银行行长会议主席,以及12家联邦储备银行信息技术监督委员会主席。此前,从2001年到2005年,Fisher先生是Kissinger McLarty Associates(一家战略咨询公司)的副董事长。Fisher从1997年到2001年担任美国副贸易代表,大使级别。Fisher先生目前担任Barclays PLC(一家领先的投资银行)的高级顾问,以及德克萨斯大学西南医学基金会的受托人。Fisher先生在哈佛大学获得经济学学士学位,并在斯坦福大学获得工商管理硕士学位。


Richard Fisher,served as President and Chief Executive Officer of the Federal Reserve Bank of Dallas from 2005 until 2015. During his tenure, he served as a member of the Federal Open Market Policy Committee, as the chair of the Conference of Federal Reserve Bank Presidents, and as the chair of the Information Technology Oversight Committee for the 12 Federal Reserve banks.Previously, from 2001 to 2005, he was Vice Chairman of Kissinger McLarty Associates, a strategic advisory firm.From 1997 to 2001, Mr. Fisher served as Deputy U.S. Trade Representative with the rank of Ambassador.Over the last 10 years, Mr. Fisher has served in a number of advisory roles, including Senior Advisor for Barclays PLC, a leading investment bank, from 2015 to 2024; most recently, he was appointed as a Senior Advisor for Jeffries Financial Group Inc. in April 2024 and as a Senior Advisor to the Texas Stock Exchange (TXSE) in July 2024.He has also served as a Trustee of the University of Texas Southwestern Medical Foundation.Mr. Fisher received his B.A. in economics from Harvard University and earned his M.B.A. from Stanford University.
Richard Fisher从2005年到2015年担任达拉斯联邦储备银行的总裁兼首席执行官。任职期间,他曾担任联邦公开市场政策委员会成员,联邦储备银行行长会议主席,以及12家联邦储备银行信息技术监督委员会主席。此前,从2001年到2005年,Fisher先生是Kissinger McLarty Associates(一家战略咨询公司)的副董事长。Fisher从1997年到2001年担任美国副贸易代表,大使级别。Fisher先生目前担任Barclays PLC(一家领先的投资银行)的高级顾问,以及德克萨斯大学西南医学基金会的受托人。Fisher先生在哈佛大学获得经济学学士学位,并在斯坦福大学获得工商管理硕士学位。
Richard Fisher,served as President and Chief Executive Officer of the Federal Reserve Bank of Dallas from 2005 until 2015. During his tenure, he served as a member of the Federal Open Market Policy Committee, as the chair of the Conference of Federal Reserve Bank Presidents, and as the chair of the Information Technology Oversight Committee for the 12 Federal Reserve banks.Previously, from 2001 to 2005, he was Vice Chairman of Kissinger McLarty Associates, a strategic advisory firm.From 1997 to 2001, Mr. Fisher served as Deputy U.S. Trade Representative with the rank of Ambassador.Over the last 10 years, Mr. Fisher has served in a number of advisory roles, including Senior Advisor for Barclays PLC, a leading investment bank, from 2015 to 2024; most recently, he was appointed as a Senior Advisor for Jeffries Financial Group Inc. in April 2024 and as a Senior Advisor to the Texas Stock Exchange (TXSE) in July 2024.He has also served as a Trustee of the University of Texas Southwestern Medical Foundation.Mr. Fisher received his B.A. in economics from Harvard University and earned his M.B.A. from Stanford University.
Cecil D. Haney

Cecil D. Haney,美国海军退役上将;2013年至2016年,美国战略司令部指挥官;2012年至2013年,他担任美国太平洋舰队司令。


Cecil D. Haney,is a retired four-star Admiral, who completed 38 years of service in the U.S. Navy in 2017.Between 2013 and 2016, he also served as commander of the U.S. Strategic Command, where he was responsible for strategic capabilities involving nuclear forces, missile defense, space and cyberspace.In addition, between 2012 and 2013, he also served as commander of the U.S. Pacific Fleet, leading the U.S. Navy's operations and the manning, operations and maintenance of the U.S. Navy fleet located in the Pacific and Indian oceans.He currently serves on the Johns Hopkins University Applied Physics Board of Managers, the Penn State University Applied Research Lab Advisory Board, the Naval Studies Board, the Aerospace Corporation Board of Trustees, and the Board of Directors for General Dynamics Corporation, Systems Planning and Analysis, Inc., and the Center for New American Security.He also serves as Chairman of the Board of Directors for the Military Child Education Coalition.Admiral Haney is a graduate of the U.S. Naval Academy and holds Master's degrees in National Security Strategy from the National Defense University and in Engineering Acoustics and System Technology from the Naval Post Graduate School.
Cecil D. Haney,美国海军退役上将;2013年至2016年,美国战略司令部指挥官;2012年至2013年,他担任美国太平洋舰队司令。
Cecil D. Haney,is a retired four-star Admiral, who completed 38 years of service in the U.S. Navy in 2017.Between 2013 and 2016, he also served as commander of the U.S. Strategic Command, where he was responsible for strategic capabilities involving nuclear forces, missile defense, space and cyberspace.In addition, between 2012 and 2013, he also served as commander of the U.S. Pacific Fleet, leading the U.S. Navy's operations and the manning, operations and maintenance of the U.S. Navy fleet located in the Pacific and Indian oceans.He currently serves on the Johns Hopkins University Applied Physics Board of Managers, the Penn State University Applied Research Lab Advisory Board, the Naval Studies Board, the Aerospace Corporation Board of Trustees, and the Board of Directors for General Dynamics Corporation, Systems Planning and Analysis, Inc., and the Center for New American Security.He also serves as Chairman of the Board of Directors for the Military Child Education Coalition.Admiral Haney is a graduate of the U.S. Naval Academy and holds Master's degrees in National Security Strategy from the National Defense University and in Engineering Acoustics and System Technology from the Naval Post Graduate School.
Nadja Y. West

Nadja Y. West,服役37年后以中将军衔从美国陆军退役。2015年至2019年,West将军担任第44任美国陆军外科医生兼美国陆军医疗司令部司令。在此之前,West将军从2013年到2015年担任联合参谋部外科医生,担任参谋长联席会议主席的首席医疗顾问。她还曾担任欧洲区域医疗司令部司令和布拉格堡沃马克陆军医疗中心司令。她是许多军事奖项的获得者,包括杰出服务奖章,国防高级服务奖章和功绩军团。West将军是国防部自杀预防和反应独立审查委员会的顾问。她还担任Johnson & Johnson和Tenet Healthcare Corporation的董事。


Nadja Y. West,is a retired Lieutenant General in the U.S. Army, the 44th Surgeon General of the U.S. Army and the former Commanding General of the U.S. Army Medical Command.Previously, she served as Joint Staff Surgeon at the Pentagon, where she acted as chief medical advisor to the Chairman of the Joint Chiefs of Staff and coordinated all related health services issues, including operational medicine, force health protection and readiness within the military.Dr. West has served in combat deployment, as well as in leadership positions in multiple hospitals, both in the United States and abroad.She is the recipient of numerous U.S. military awards, including the Distinguished Service Medal, the Defense Superior Service Medal, and the Legion of Merit with three Oak Leaf Clusters.She has served as an independent director of Nucor Corporation since 2019 and Johnson & Johnson since 2020.Dr. West has served as a trustee on the Board of the National Recreation Foundation, a non-profit organization dedicated to enhancing the role of recreation as a positive force in improving the quality of life of youth, since 2019.Dr. West is a graduate of the U.S. Military Academy and earned her medical degree from The George Washington University School of Medicine in Washington, D.C.She has completed residencies in both family medicine and dermatology.
Nadja Y. West,服役37年后以中将军衔从美国陆军退役。2015年至2019年,West将军担任第44任美国陆军外科医生兼美国陆军医疗司令部司令。在此之前,West将军从2013年到2015年担任联合参谋部外科医生,担任参谋长联席会议主席的首席医疗顾问。她还曾担任欧洲区域医疗司令部司令和布拉格堡沃马克陆军医疗中心司令。她是许多军事奖项的获得者,包括杰出服务奖章,国防高级服务奖章和功绩军团。West将军是国防部自杀预防和反应独立审查委员会的顾问。她还担任Johnson & Johnson和Tenet Healthcare Corporation的董事。
Nadja Y. West,is a retired Lieutenant General in the U.S. Army, the 44th Surgeon General of the U.S. Army and the former Commanding General of the U.S. Army Medical Command.Previously, she served as Joint Staff Surgeon at the Pentagon, where she acted as chief medical advisor to the Chairman of the Joint Chiefs of Staff and coordinated all related health services issues, including operational medicine, force health protection and readiness within the military.Dr. West has served in combat deployment, as well as in leadership positions in multiple hospitals, both in the United States and abroad.She is the recipient of numerous U.S. military awards, including the Distinguished Service Medal, the Defense Superior Service Medal, and the Legion of Merit with three Oak Leaf Clusters.She has served as an independent director of Nucor Corporation since 2019 and Johnson & Johnson since 2020.Dr. West has served as a trustee on the Board of the National Recreation Foundation, a non-profit organization dedicated to enhancing the role of recreation as a positive force in improving the quality of life of youth, since 2019.Dr. West is a graduate of the U.S. Military Academy and earned her medical degree from The George Washington University School of Medicine in Washington, D.C.She has completed residencies in both family medicine and dermatology.
Meghan M. FitzGerald

MeghanM.FitzGerald是一名私人股本投资者,在那里她担任多家公司的顾问,包括Wellspring Capital。此外,Fitzgerald女士还担任哥伦比亚大学卫生政策的兼职副教授。Fitzgerald女士从2016年12月到2020年1月担任Letter One’;S首次健康车辆的首席执行官和管理合伙人。在此之前,她曾担任许多医疗保健公司(包括Merck,Pfizer和Medco)的运营商和策略师近20年。从2015年5月到2016年10月,Fitzgerald女士担任Cardinal Health(一家医疗保健服务和产品公司)战略和政策执行副总裁。从2010年到2015年,她担任Cardinal’;S专业解决方案部门的总裁。Fitzgerald女士目前还担任ThimblePoint Acquisition Corp的董事,此前曾于2017年7月至2019年4月担任Arix Bioscience PLC的董事。她是K2HealthVentures(生命科学投资基金)的创始人,也是TrekMedics(国际科技非营利组织)的顾问和志愿者。她拥有纽约医学院(New York Medical College)的医疗保健政策博士学位,费尔菲尔德大学(Fairfield University)的护理学士学位,哥伦比亚大学(Columbia University)的公共卫生硕士学位。


Meghan M. FitzGerald,is a private equity investor, and she serves as an advisor to several firms, including Goldman Sachs, TowerBrook and Wellspring Capital, a private equity firm focused on leveraged buyout investments.In addition, she serves as an Adjunct Professor of Health Policy at Columbia University, a private university.Ms. FitzGerald served from December 2016 to January 2020 as the CEO and managing partner at Letter One's inaugural health vehicle.Prior to that, she served for nearly 20 years as an operator and strategist working for many healthcare firms, including Merck, Pfizer and Medco.From May 2015 to October 2016, Ms. FitzGerald served as Executive Vice President of Strategy and Policy at Cardinal Health, a healthcare services and product company. From 2010 to 2015, she served as President of Cardinal's Specialty Solutions division.Ms. FitzGerald also previously served as a director of Thimble Point Acquisition Corp. from February to December 2021 and Arix Bioscience plc from 2017 to 2019.She is the founder of K2HealthVentures, a life science investment fund.She holds a DrPH in Healthcare Policy from New York Medical College, a BSN in Nursing from Fairfield University, and a Master of Public Health from Columbia University.
MeghanM.FitzGerald是一名私人股本投资者,在那里她担任多家公司的顾问,包括Wellspring Capital。此外,Fitzgerald女士还担任哥伦比亚大学卫生政策的兼职副教授。Fitzgerald女士从2016年12月到2020年1月担任Letter One’;S首次健康车辆的首席执行官和管理合伙人。在此之前,她曾担任许多医疗保健公司(包括Merck,Pfizer和Medco)的运营商和策略师近20年。从2015年5月到2016年10月,Fitzgerald女士担任Cardinal Health(一家医疗保健服务和产品公司)战略和政策执行副总裁。从2010年到2015年,她担任Cardinal’;S专业解决方案部门的总裁。Fitzgerald女士目前还担任ThimblePoint Acquisition Corp的董事,此前曾于2017年7月至2019年4月担任Arix Bioscience PLC的董事。她是K2HealthVentures(生命科学投资基金)的创始人,也是TrekMedics(国际科技非营利组织)的顾问和志愿者。她拥有纽约医学院(New York Medical College)的医疗保健政策博士学位,费尔菲尔德大学(Fairfield University)的护理学士学位,哥伦比亚大学(Columbia University)的公共卫生硕士学位。
Meghan M. FitzGerald,is a private equity investor, and she serves as an advisor to several firms, including Goldman Sachs, TowerBrook and Wellspring Capital, a private equity firm focused on leveraged buyout investments.In addition, she serves as an Adjunct Professor of Health Policy at Columbia University, a private university.Ms. FitzGerald served from December 2016 to January 2020 as the CEO and managing partner at Letter One's inaugural health vehicle.Prior to that, she served for nearly 20 years as an operator and strategist working for many healthcare firms, including Merck, Pfizer and Medco.From May 2015 to October 2016, Ms. FitzGerald served as Executive Vice President of Strategy and Policy at Cardinal Health, a healthcare services and product company. From 2010 to 2015, she served as President of Cardinal's Specialty Solutions division.Ms. FitzGerald also previously served as a director of Thimble Point Acquisition Corp. from February to December 2021 and Arix Bioscience plc from 2017 to 2019.She is the founder of K2HealthVentures, a life science investment fund.She holds a DrPH in Healthcare Policy from New York Medical College, a BSN in Nursing from Fairfield University, and a Master of Public Health from Columbia University.
Saumya Sutaria

Saumya Sutaria于2019年1月被任命为公司首席运营官,于2019年11月被任命为总裁,并于2020年11月被任命为董事会成员。在加入公司之前,Sutaria博士在McKinsey&Company工作了18年,最近担任高级合伙人,为医院、医疗保健系统、医师团体、门诊护理模型、综合交付和政府主导的交付提供咨询支持,同时还与医疗保健的机构投资者合作。此前,他曾在加州大学旧金山分校(University of California at San Francisco)担任副临床教员,在那里他还从事以内科和心脏病学为重点的研究生培训。Sutaria博士在加州大学伯克利分校获得分子和细胞生物学学士学位和经济学学士学位,并在加州大学圣地亚哥分校获得医学学位。


Saumya Sutaria,was appointed Chairman of the Board in August 2023. He was appointed as the Company's Chief Executive Officer in September 2021, and as a member of the Board in November 2020.Prior to becoming Chief Executive Officer, he served as the Company's Chief Operating Officer from January 2019 to September 2021 and President from November 2019 to September 2021.Before joining the Company, Dr. Sutaria worked for McKinsey & Company, a global management consulting firm, for 18 years, most recently as a Senior Partner providing advisory support for hospitals, healthcare systems, physicians groups, ambulatory care models, integrated delivery, and government-led delivery, while also working with institutional investors in healthcare.He previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology.Dr. Sutaria received his Bachelor's Degree in molecular and cellular biology and his Bachelor's Degree in economics, both from the University of California, Berkeley, as well as his Medical Degree from the University of California, San Diego.
Saumya Sutaria于2019年1月被任命为公司首席运营官,于2019年11月被任命为总裁,并于2020年11月被任命为董事会成员。在加入公司之前,Sutaria博士在McKinsey&Company工作了18年,最近担任高级合伙人,为医院、医疗保健系统、医师团体、门诊护理模型、综合交付和政府主导的交付提供咨询支持,同时还与医疗保健的机构投资者合作。此前,他曾在加州大学旧金山分校(University of California at San Francisco)担任副临床教员,在那里他还从事以内科和心脏病学为重点的研究生培训。Sutaria博士在加州大学伯克利分校获得分子和细胞生物学学士学位和经济学学士学位,并在加州大学圣地亚哥分校获得医学学位。
Saumya Sutaria,was appointed Chairman of the Board in August 2023. He was appointed as the Company's Chief Executive Officer in September 2021, and as a member of the Board in November 2020.Prior to becoming Chief Executive Officer, he served as the Company's Chief Operating Officer from January 2019 to September 2021 and President from November 2019 to September 2021.Before joining the Company, Dr. Sutaria worked for McKinsey & Company, a global management consulting firm, for 18 years, most recently as a Senior Partner providing advisory support for hospitals, healthcare systems, physicians groups, ambulatory care models, integrated delivery, and government-led delivery, while also working with institutional investors in healthcare.He previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology.Dr. Sutaria received his Bachelor's Degree in molecular and cellular biology and his Bachelor's Degree in economics, both from the University of California, Berkeley, as well as his Medical Degree from the University of California, San Diego.
James L. Bierman

James L. Bierman,2014年9月至2015年6月担任Owens & Minor, Inc.(纽约证券交易所代码:OMI)总裁兼首席执行官和董事会成员,该公司是一家财富500强公司,也是医疗和手术用品的主要分销商。此前,他在欧麦斯-麦能医疗担任过多个高级职务,包括2013年8月至2014年9月担任总裁兼首席运营官,2012年3月至2013年8月担任执行副总裁兼首席运营官,2011年4月至2012年3月担任执行副总裁兼首席财务官,2007年6月至2011年4月担任高级副总裁兼首席财务官。在其职业生涯的早期,比尔曼先生曾在Quintiles Transnational Corp.(前纳斯达克:QTRN)担任执行副总裁兼首席财务官。昆泰是为制药、生物技术和医疗器械行业提供产品开发和商业化解决方案的市场领导者。在加入昆泰公司之前,比尔曼曾在1988年至1998年期间担任安达信律师事务所的合伙人。Bierman先生目前担任泰尼特保健公司(纽约证券交易所代码:THC)和Novan, Inc.(纳斯达克:NOVN)的董事会成员。Tenet Healthcare Corporation(纽约证券交易所代码:TERM1)是一家财富500强公司,也是一家多元化的医疗保健服务公司,在美国各地经营着600多家设施、急症医院和门诊中心。Novan,Inc.是一家医学皮肤病公司,主要致力于研究、开发和商业化治疗皮肤病的创新产品。在他担任董事期间,该公司既收购了其皮肤病学平台,又向美国食品药品监督管理局(FDA)提交了首份新药申请(NDA),寻求获得贝达西默凝胶(10.3%)的上市许可,用于局部治疗传染性软疣。比尔曼先生最近担任KL Acquisition公司(前纳斯达克:KLAQU)的独立董事,并担任董事会审计委员会主席。他于2021年1月被任命为董事会成员。该公司是一家注册空白支票公司(SPAC),其业务目的是与一个或多个企业或实体进行合并或类似的业务合并。首次公开发行于2021年1月完成,筹资超过2.5亿美元。该公司没有完成最初的业务合并,并于2022年12月16日通知纳斯达克其赎回、清算和解散的意图。它提交了必要的表格,以便在2022年12月30日之前将该公司的证券摘牌,并允许该公司解除和赎回其所有已发行的公众股票。Bierman先生曾担任Team Health Holdings, Inc.(前纽约证券交易所代码:TMH)董事会的首席独立董事。Team Health是美国向医院和其他医疗保健提供者提供外包医疗保健专业人员和行政服务的最大供应商之一。比尔曼在迪金森学院获得了学士学位,在康奈尔大学约翰逊管理研究生院获得了MBA学位。


James L. Bierman,served as President and Chief Executive Officer of Owens & Minor, Inc., a Fortune 500 company and a leading distributor of medical and surgical supplies, from September 2014 to June 2015.Previously, he served in various other senior roles at Owens & Minor, including President and Chief Operating Officer from August 2013 to September 2014, Executive Vice President and Chief Operating Officer from March 2012 to August 2013, Executive Vice President and Chief Financial Officer from April 2011 to March 2012, and Senior Vice President and Chief Financial Officer from June 2007 to April 2011.From 2001 to 2004, Mr. Bierman served as Executive Vice President and Chief Financial Officer at Quintiles Transnational Corp. Prior to joining Quintiles Transnational, he was a partner at Arthur Andersen LLP.Mr. Bierman earned his B.A. from Dickinson College and his M.B.A. from Cornell University's Johnson Graduate School of Management.
James L. Bierman,2014年9月至2015年6月担任Owens & Minor, Inc.(纽约证券交易所代码:OMI)总裁兼首席执行官和董事会成员,该公司是一家财富500强公司,也是医疗和手术用品的主要分销商。此前,他在欧麦斯-麦能医疗担任过多个高级职务,包括2013年8月至2014年9月担任总裁兼首席运营官,2012年3月至2013年8月担任执行副总裁兼首席运营官,2011年4月至2012年3月担任执行副总裁兼首席财务官,2007年6月至2011年4月担任高级副总裁兼首席财务官。在其职业生涯的早期,比尔曼先生曾在Quintiles Transnational Corp.(前纳斯达克:QTRN)担任执行副总裁兼首席财务官。昆泰是为制药、生物技术和医疗器械行业提供产品开发和商业化解决方案的市场领导者。在加入昆泰公司之前,比尔曼曾在1988年至1998年期间担任安达信律师事务所的合伙人。Bierman先生目前担任泰尼特保健公司(纽约证券交易所代码:THC)和Novan, Inc.(纳斯达克:NOVN)的董事会成员。Tenet Healthcare Corporation(纽约证券交易所代码:TERM1)是一家财富500强公司,也是一家多元化的医疗保健服务公司,在美国各地经营着600多家设施、急症医院和门诊中心。Novan,Inc.是一家医学皮肤病公司,主要致力于研究、开发和商业化治疗皮肤病的创新产品。在他担任董事期间,该公司既收购了其皮肤病学平台,又向美国食品药品监督管理局(FDA)提交了首份新药申请(NDA),寻求获得贝达西默凝胶(10.3%)的上市许可,用于局部治疗传染性软疣。比尔曼先生最近担任KL Acquisition公司(前纳斯达克:KLAQU)的独立董事,并担任董事会审计委员会主席。他于2021年1月被任命为董事会成员。该公司是一家注册空白支票公司(SPAC),其业务目的是与一个或多个企业或实体进行合并或类似的业务合并。首次公开发行于2021年1月完成,筹资超过2.5亿美元。该公司没有完成最初的业务合并,并于2022年12月16日通知纳斯达克其赎回、清算和解散的意图。它提交了必要的表格,以便在2022年12月30日之前将该公司的证券摘牌,并允许该公司解除和赎回其所有已发行的公众股票。Bierman先生曾担任Team Health Holdings, Inc.(前纽约证券交易所代码:TMH)董事会的首席独立董事。Team Health是美国向医院和其他医疗保健提供者提供外包医疗保健专业人员和行政服务的最大供应商之一。比尔曼在迪金森学院获得了学士学位,在康奈尔大学约翰逊管理研究生院获得了MBA学位。
James L. Bierman,served as President and Chief Executive Officer of Owens & Minor, Inc., a Fortune 500 company and a leading distributor of medical and surgical supplies, from September 2014 to June 2015.Previously, he served in various other senior roles at Owens & Minor, including President and Chief Operating Officer from August 2013 to September 2014, Executive Vice President and Chief Operating Officer from March 2012 to August 2013, Executive Vice President and Chief Financial Officer from April 2011 to March 2012, and Senior Vice President and Chief Financial Officer from June 2007 to April 2011.From 2001 to 2004, Mr. Bierman served as Executive Vice President and Chief Financial Officer at Quintiles Transnational Corp. Prior to joining Quintiles Transnational, he was a partner at Arthur Andersen LLP.Mr. Bierman earned his B.A. from Dickinson College and his M.B.A. from Cornell University's Johnson Graduate School of Management.
Roy Blunt

罗伊·布朗特(Roy Blunt),密苏里州参议员、众议员;1950年1月10日出生于密苏里州韦伯斯特县年瓜阿;1970年毕业于密苏里州玻利瓦尔西南浸会大学,获得学士学位;1972年毕业于密苏里州斯普林菲尔德密苏里州立大学,获得硕士学位;高中历史教师;密苏里州格林县书记和首席选举官。1973-1984年;密苏里州州务卿1984-1993年;密苏里州玻利瓦尔西南浸会大学校长,1993-1996年;作为共和党人当选为第一百五大和随后的六届国会议员(1997年1月3日-2011年1月3日);多数党党鞭(第一百八届至第一百九大);代理多数党领袖(第一百九大,9月28日,2005年-2006年2月2日);少数党党鞭(第一百一十届国会);不是众议院连任候选人,但在2010年以共和党人身份当选美国参议院;2016年连任,任职时间为2011年1月3日,至2023年1月3日;共和党大会副主席(2012-2018年);共和党政策委员会主席(2019-2023年);规则与行政委员会主席(第一百十四届国会、第一百十五届国会[ 2017年1月3日-2017年1月20日;2018年4月10日-2019年1月3日]、第一百十六届国会);不是2022年参议院连任候选人。


Roy Blunt,A Senator and a Representative from Missouri; born in Niangua, Webster County, Mo., January 10, 1950; graduated Southwest Baptist University, Bolivar, Mo., B.A., 1970;He graduated Missouri State University, Springfield, Mo., M.A., 1972; high school history teacher; clerk and chief election officer, Greene County, Mo. 1973-1984; Missouri state secretary of state 1984-1993; president, Southwest Baptist University, Bolivar, Mo. 1993-1996; elected as a Republican to the One Hundred Fifth and to the six succeeding Congresses (January 3, 1997-January 3, 2011); majority whip (One Hundred Eighth through One Hundred Ninth Congresses); acting majority leader (One Hundred Ninth Congress, September 28, 2005-February 2, 2006); minority whip (One Hundred Tenth Congress); was not a candidate for reelection to the House of Representatives but was elected as a Republican to the United States Senate in 2010; reelected in 2016, and served from January 3, 2011, to January 3, 2023; vice-chair, Republican Conference (2012-2018); chair, Republican Policy Committee (2019-2023); chair, Committee on Rules and Administration (One Hundred Fourteenth Congress, One Hundred Fifteenth Congress [January 3, 2017-January 20, 2017; April 10, 2018-January 3, 2019], and One Hundred Sixteenth Congress); was not a candidate for reelection to the Senate in 2022.
罗伊·布朗特(Roy Blunt),密苏里州参议员、众议员;1950年1月10日出生于密苏里州韦伯斯特县年瓜阿;1970年毕业于密苏里州玻利瓦尔西南浸会大学,获得学士学位;1972年毕业于密苏里州斯普林菲尔德密苏里州立大学,获得硕士学位;高中历史教师;密苏里州格林县书记和首席选举官。1973-1984年;密苏里州州务卿1984-1993年;密苏里州玻利瓦尔西南浸会大学校长,1993-1996年;作为共和党人当选为第一百五大和随后的六届国会议员(1997年1月3日-2011年1月3日);多数党党鞭(第一百八届至第一百九大);代理多数党领袖(第一百九大,9月28日,2005年-2006年2月2日);少数党党鞭(第一百一十届国会);不是众议院连任候选人,但在2010年以共和党人身份当选美国参议院;2016年连任,任职时间为2011年1月3日,至2023年1月3日;共和党大会副主席(2012-2018年);共和党政策委员会主席(2019-2023年);规则与行政委员会主席(第一百十四届国会、第一百十五届国会[ 2017年1月3日-2017年1月20日;2018年4月10日-2019年1月3日]、第一百十六届国会);不是2022年参议院连任候选人。
Roy Blunt,A Senator and a Representative from Missouri; born in Niangua, Webster County, Mo., January 10, 1950; graduated Southwest Baptist University, Bolivar, Mo., B.A., 1970;He graduated Missouri State University, Springfield, Mo., M.A., 1972; high school history teacher; clerk and chief election officer, Greene County, Mo. 1973-1984; Missouri state secretary of state 1984-1993; president, Southwest Baptist University, Bolivar, Mo. 1993-1996; elected as a Republican to the One Hundred Fifth and to the six succeeding Congresses (January 3, 1997-January 3, 2011); majority whip (One Hundred Eighth through One Hundred Ninth Congresses); acting majority leader (One Hundred Ninth Congress, September 28, 2005-February 2, 2006); minority whip (One Hundred Tenth Congress); was not a candidate for reelection to the House of Representatives but was elected as a Republican to the United States Senate in 2010; reelected in 2016, and served from January 3, 2011, to January 3, 2023; vice-chair, Republican Conference (2012-2018); chair, Republican Policy Committee (2019-2023); chair, Committee on Rules and Administration (One Hundred Fourteenth Congress, One Hundred Fifteenth Congress [January 3, 2017-January 20, 2017; April 10, 2018-January 3, 2019], and One Hundred Sixteenth Congress); was not a candidate for reelection to the Senate in 2022.
Vineeta Agarwala

Vineeta Agarwala曾担任风险投资公司Andreessen Horowitz(a16z)的普通合伙人,在那里她领导该公司的生物+健康基金的投资,横跨生物技术和数字健康。此外,她自2020年以来一直担任斯坦福大学医学院的兼职临床助理教授。2016年8月至2018年6月,Agarwala博士在Flatiron Health担任产品管理总监,在那里她领导该公司与Foundation Medicine合作,将真实世界的临床和基因组数据整合到国家规模的数据产品中,以加速肿瘤学的研发。在2015年3月至2019年12月期间,她是GV(Google Ventures)生命科学团队的风险投资人。Agarwala拥有哈佛医学院/麻省理工学院的医学博士和博士学位,以及斯坦福大学的生物物理学学士学位。她在斯坦福大学完成了临床实习,并获得了内科医学的董事会认证。


Vineeta Agarwala,has served as a General Partner at Andreessen Horowitz (a16z), a venture capital firm, where she leads investments for the firm's Bio + Health fund across biotech and digital health.In addition, she has served as an Adjunct Clinical Assistant Professor at Stanford University School of Medicine since 2020.From August 2016 to June 2018, Dr. Agarwala served as Director of Product Management at Flatiron Health, where she led the company's partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale data products to accelerate research and development in oncology.Between March 2015 and December 2019, she was a venture investor on the GV (Google Ventures) life sciences team.Dr. Agarwala holds M.D. and Ph.D. degrees from Harvard Medical School / MIT, and a B.S. degree in biophysics from Stanford University.She completed her clinical residency at Stanford and is board certified in internal medicine.
Vineeta Agarwala曾担任风险投资公司Andreessen Horowitz(a16z)的普通合伙人,在那里她领导该公司的生物+健康基金的投资,横跨生物技术和数字健康。此外,她自2020年以来一直担任斯坦福大学医学院的兼职临床助理教授。2016年8月至2018年6月,Agarwala博士在Flatiron Health担任产品管理总监,在那里她领导该公司与Foundation Medicine合作,将真实世界的临床和基因组数据整合到国家规模的数据产品中,以加速肿瘤学的研发。在2015年3月至2019年12月期间,她是GV(Google Ventures)生命科学团队的风险投资人。Agarwala拥有哈佛医学院/麻省理工学院的医学博士和博士学位,以及斯坦福大学的生物物理学学士学位。她在斯坦福大学完成了临床实习,并获得了内科医学的董事会认证。
Vineeta Agarwala,has served as a General Partner at Andreessen Horowitz (a16z), a venture capital firm, where she leads investments for the firm's Bio + Health fund across biotech and digital health.In addition, she has served as an Adjunct Clinical Assistant Professor at Stanford University School of Medicine since 2020.From August 2016 to June 2018, Dr. Agarwala served as Director of Product Management at Flatiron Health, where she led the company's partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale data products to accelerate research and development in oncology.Between March 2015 and December 2019, she was a venture investor on the GV (Google Ventures) life sciences team.Dr. Agarwala holds M.D. and Ph.D. degrees from Harvard Medical School / MIT, and a B.S. degree in biophysics from Stanford University.She completed her clinical residency at Stanford and is board certified in internal medicine.
Christopher S. Lynch

Christopher S. Lynch自2007年以来一直是一个独立顾问,为公共和私人持有的金融中介机构,包括企业重组、风险管理、战略、治理、财务会计和监管报告以及陷入困境的资产管理提供各种服务。Lynch先生是KPMG LLP的金融服务商业线的前国家合作伙伴。1979至2007年,他在KPMG 担任过各种职务,包括担任 KPMG美洲金融服务的领导团队主席,全球金融服务领导和美国产业领导小组的成员。Lynch先生根据萨班斯法案和 KPMG一些最大的金融服务客户成为审计签约的合伙人。他还担任过 KPMG专业实践国家部门的合伙人,并在财务会计准则委员会担任实践研究员。Lynch先生是斯坦福大学经济政策研究所的顾问委员会的成员,全国审计委员会顾问委员会的成员。Lynch先生目前就职于Federal Home Loan Mortgage Corporation,在那里他是执行委员会主席,同时也是审计委员会和薪酬委员会成员。


Christopher S. Lynch,served as National Partner in Charge of the Financial Services practice at KPMG, LLC from 2004 until his retirement in 2007.Prior to that, Mr. Lynch held a variety of positions at KPMG during his 29-year tenure, including chair of KPMG's Americas Financial Services Leadership team and a member of the Global Financial Services Leadership and U.S. Industries Leadership teams.From 2009 to 2022, he served as an independent director of American International Group, Inc. (AIG).From 2008 to 2019, he also served as an independent director of Freddie Mac and was the Non-Executive Chairman of the Board from 2011 to 2018.Mr. Lynch has chaired audit committees of both AIG and Freddie Mac and has relevant committee experience on Risk, Compensation, Nomination and Corporate Governance and Technology.Mr. Lynch is a former member of the Advisory Board of the Stanford Institute for Economic Policy Research and a member of the Audit Committee Chair Advisory Council of the National Association of Corporate Directors.He received a Bachelor of Science in Accounting and Business Administration from the University of Kansas.
Christopher S. Lynch自2007年以来一直是一个独立顾问,为公共和私人持有的金融中介机构,包括企业重组、风险管理、战略、治理、财务会计和监管报告以及陷入困境的资产管理提供各种服务。Lynch先生是KPMG LLP的金融服务商业线的前国家合作伙伴。1979至2007年,他在KPMG 担任过各种职务,包括担任 KPMG美洲金融服务的领导团队主席,全球金融服务领导和美国产业领导小组的成员。Lynch先生根据萨班斯法案和 KPMG一些最大的金融服务客户成为审计签约的合伙人。他还担任过 KPMG专业实践国家部门的合伙人,并在财务会计准则委员会担任实践研究员。Lynch先生是斯坦福大学经济政策研究所的顾问委员会的成员,全国审计委员会顾问委员会的成员。Lynch先生目前就职于Federal Home Loan Mortgage Corporation,在那里他是执行委员会主席,同时也是审计委员会和薪酬委员会成员。
Christopher S. Lynch,served as National Partner in Charge of the Financial Services practice at KPMG, LLC from 2004 until his retirement in 2007.Prior to that, Mr. Lynch held a variety of positions at KPMG during his 29-year tenure, including chair of KPMG's Americas Financial Services Leadership team and a member of the Global Financial Services Leadership and U.S. Industries Leadership teams.From 2009 to 2022, he served as an independent director of American International Group, Inc. (AIG).From 2008 to 2019, he also served as an independent director of Freddie Mac and was the Non-Executive Chairman of the Board from 2011 to 2018.Mr. Lynch has chaired audit committees of both AIG and Freddie Mac and has relevant committee experience on Risk, Compensation, Nomination and Corporate Governance and Technology.Mr. Lynch is a former member of the Advisory Board of the Stanford Institute for Economic Policy Research and a member of the Audit Committee Chair Advisory Council of the National Association of Corporate Directors.He received a Bachelor of Science in Accounting and Business Administration from the University of Kansas.
J. Robert Kerrey

J. Robert Kerrey是来自内布拉斯加州的前任州长和美国参议员。他自2014年1月以来担任投资银行公司Allen & Company的董事总经理。他自2013年1月以来担任The Minerva Institute for Research and Scholarship(非营利机构,旨在为学生提供特殊教育经验和推进教师研究)的执行董事长。从2011年1月至2013年2月纽约城The New School University的名誉主席,从2001年到2010年他是The New School University的总裁。从2011年7月到2012年3月,他担任M & F Worldwide Education Holdings(业务和家庭办公区、技术、数据管理和教育产品和服务提供商)的主席。从1989年1月至2000年12月,他担任美国内布拉斯加州参议员。在选举到美国参议院之前,他从1982年1月至1987年12月是内布拉斯加州的州长。进入公共服务之前,他创办并经营一家连锁餐厅和健身俱乐部。作为精英海豹突击队(Navy SEAL Team)的前任成员,他是高度装饰的越战老兵,被授予国会荣誉勋章(Congressional Medal of Honor)——美国的最高军事荣誉。他获得Nebraska大学的药学学士学位。他目前担任两个上市公司——Chart Acquisition Corp.和U.S. Rare Earths, Inc.的董事,他之前担任Genworth Financial, Inc., Jones Apparel Group, Inc.和Scientific Games Corporation的董事。


J. Robert Kerrey,is a former governor and U.S. Senator from Nebraska.He has served as managing director at Allen & Company, an investment banking firm, since 2014. He has also served as Executive Chairman of The Minerva Institute for Research and Scholarship, a non-profit that offers exceptional educational experiences to students and advances faculty research, since 2013.From 2011 to 2013, Senator Kerrey was President Emeritus of The New School University in New York City, where he served as President from 2001 to 2010.From 2011 to 2012, he served as the Chairman of M & F Worldwide Education Holdings.From 1989 to 2000, he served as a U.S. Senator for the State of Nebraska.Previously, Senator Kerrey was Governor of the State of Nebraska from 1982 to 1987.Prior to public service, he founded and operated a chain of restaurants and health clubs.A former member of the elite Navy SEAL Team, Senator Kerrey is a highly decorated Vietnam veteran who was awarded the Congressional Medal of Honor – America's highest military honor.He holds a degree in pharmacy from the University of Nebraska.
J. Robert Kerrey是来自内布拉斯加州的前任州长和美国参议员。他自2014年1月以来担任投资银行公司Allen & Company的董事总经理。他自2013年1月以来担任The Minerva Institute for Research and Scholarship(非营利机构,旨在为学生提供特殊教育经验和推进教师研究)的执行董事长。从2011年1月至2013年2月纽约城The New School University的名誉主席,从2001年到2010年他是The New School University的总裁。从2011年7月到2012年3月,他担任M & F Worldwide Education Holdings(业务和家庭办公区、技术、数据管理和教育产品和服务提供商)的主席。从1989年1月至2000年12月,他担任美国内布拉斯加州参议员。在选举到美国参议院之前,他从1982年1月至1987年12月是内布拉斯加州的州长。进入公共服务之前,他创办并经营一家连锁餐厅和健身俱乐部。作为精英海豹突击队(Navy SEAL Team)的前任成员,他是高度装饰的越战老兵,被授予国会荣誉勋章(Congressional Medal of Honor)——美国的最高军事荣誉。他获得Nebraska大学的药学学士学位。他目前担任两个上市公司——Chart Acquisition Corp.和U.S. Rare Earths, Inc.的董事,他之前担任Genworth Financial, Inc., Jones Apparel Group, Inc.和Scientific Games Corporation的董事。
J. Robert Kerrey,is a former governor and U.S. Senator from Nebraska.He has served as managing director at Allen & Company, an investment banking firm, since 2014. He has also served as Executive Chairman of The Minerva Institute for Research and Scholarship, a non-profit that offers exceptional educational experiences to students and advances faculty research, since 2013.From 2011 to 2013, Senator Kerrey was President Emeritus of The New School University in New York City, where he served as President from 2001 to 2010.From 2011 to 2012, he served as the Chairman of M & F Worldwide Education Holdings.From 1989 to 2000, he served as a U.S. Senator for the State of Nebraska.Previously, Senator Kerrey was Governor of the State of Nebraska from 1982 to 1987.Prior to public service, he founded and operated a chain of restaurants and health clubs.A former member of the elite Navy SEAL Team, Senator Kerrey is a highly decorated Vietnam veteran who was awarded the Congressional Medal of Honor – America's highest military honor.He holds a degree in pharmacy from the University of Nebraska.
Tammy Romo

Tammy Romo,自2015年7月起担任公司执行副总裁兼首席财务官。Romo女士还曾于2012年9月至2015年7月担任财务高级副总裁& 首席财务官、2010年2月至2012年9月担任规划高级副总裁、2008年9月至2010年2月担任财务规划副总裁、2006年2月至2008年8月担任副总裁财务总监、2004年9月至2006年2月担任副总裁财务主管、2002年3月至2004年9月担任投资者关系高级总监、1994年12月至2002年3月担任投资者关系总监、1994年9月至1994年12月担任投资者关系经理,1991年9月至1994年9月任财务报告经理。


Tammy Romo,retired in April 2025 as Executive Vice President and Chief Financial Officer of Southwest Airlines Co., a major passenger airline, where she was responsible for corporate strategy and overall finance activities, including reporting, accounting, investor relations, treasury, tax, corporate planning, and financial planning and analysis. She also oversaw supply chain management.Ms. Romo previously served in a number of financial management and leadership positions at Southwest Airlines, including Senior Vice President of Planning, Vice President and Controller, Vice President and Treasurer, and Senior Director of Investor Relations.Before joining Southwest Airlines in 1991, Ms. Romo was an audit manager at Coopers & Lybrand, LLP.Ms. Romo is currently a member of the McCombs School of Business Advisory Council at the University of Texas at Austin.She received a B.B.A. in accounting from the University of Texas at Austin, and she is a Certified Public Accountant in the State of Texas.
Tammy Romo,自2015年7月起担任公司执行副总裁兼首席财务官。Romo女士还曾于2012年9月至2015年7月担任财务高级副总裁& 首席财务官、2010年2月至2012年9月担任规划高级副总裁、2008年9月至2010年2月担任财务规划副总裁、2006年2月至2008年8月担任副总裁财务总监、2004年9月至2006年2月担任副总裁财务主管、2002年3月至2004年9月担任投资者关系高级总监、1994年12月至2002年3月担任投资者关系总监、1994年9月至1994年12月担任投资者关系经理,1991年9月至1994年9月任财务报告经理。
Tammy Romo,retired in April 2025 as Executive Vice President and Chief Financial Officer of Southwest Airlines Co., a major passenger airline, where she was responsible for corporate strategy and overall finance activities, including reporting, accounting, investor relations, treasury, tax, corporate planning, and financial planning and analysis. She also oversaw supply chain management.Ms. Romo previously served in a number of financial management and leadership positions at Southwest Airlines, including Senior Vice President of Planning, Vice President and Controller, Vice President and Treasurer, and Senior Director of Investor Relations.Before joining Southwest Airlines in 1991, Ms. Romo was an audit manager at Coopers & Lybrand, LLP.Ms. Romo is currently a member of the McCombs School of Business Advisory Council at the University of Texas at Austin.She received a B.B.A. in accounting from the University of Texas at Austin, and she is a Certified Public Accountant in the State of Texas.

高管简历

中英对照 |  中文 |  英文
Sun Park

Sun Park,于2016年5月成为执行副总裁,负责战略和开发。他曾担任高级副总裁,负责业务开发(从2012年11月到2016年5月)。加入公司之前,他曾担任MedImmune、AstraZeneca的多种领导职务,也曾任职Charterhouse Group International、Merrill Lynch & Company。


Sun Park,was appointed Tenet's Chief Financial Officer in January 2024 and Executive Vice President in July 2023. Mr. Park previously served as served as Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution and Strategic Global Sourcing of AmerisourceBergen Corporation ("AmerisourceBergen"), a global pharmaceutical sourcing and distribution services company, beginning in September 2018. From 2012 to September 2018, Mr. Park was Executive Vice President of Strategy and Development for AmerisourceBergen. Before joining AmerisourceBergen, Mr. Park served in various leadership roles across corporate development, corporate strategy and R&D portfolio management at MedImmune, the global biologics division of AstraZeneca. Before joining MedImmune, he held positions at Charterhouse Group International and Merrill Lynch & Company. He earned a Bachelor of Arts in Economics and a Bachelor of Arts in Biochemistry from Yale University.
Sun Park,于2016年5月成为执行副总裁,负责战略和开发。他曾担任高级副总裁,负责业务开发(从2012年11月到2016年5月)。加入公司之前,他曾担任MedImmune、AstraZeneca的多种领导职务,也曾任职Charterhouse Group International、Merrill Lynch & Company。
Sun Park,was appointed Tenet's Chief Financial Officer in January 2024 and Executive Vice President in July 2023. Mr. Park previously served as served as Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution and Strategic Global Sourcing of AmerisourceBergen Corporation ("AmerisourceBergen"), a global pharmaceutical sourcing and distribution services company, beginning in September 2018. From 2012 to September 2018, Mr. Park was Executive Vice President of Strategy and Development for AmerisourceBergen. Before joining AmerisourceBergen, Mr. Park served in various leadership roles across corporate development, corporate strategy and R&D portfolio management at MedImmune, the global biologics division of AstraZeneca. Before joining MedImmune, he held positions at Charterhouse Group International and Merrill Lynch & Company. He earned a Bachelor of Arts in Economics and a Bachelor of Arts in Biochemistry from Yale University.
Saumya Sutaria

Saumya Sutaria于2019年1月被任命为公司首席运营官,于2019年11月被任命为总裁,并于2020年11月被任命为董事会成员。在加入公司之前,Sutaria博士在McKinsey&Company工作了18年,最近担任高级合伙人,为医院、医疗保健系统、医师团体、门诊护理模型、综合交付和政府主导的交付提供咨询支持,同时还与医疗保健的机构投资者合作。此前,他曾在加州大学旧金山分校(University of California at San Francisco)担任副临床教员,在那里他还从事以内科和心脏病学为重点的研究生培训。Sutaria博士在加州大学伯克利分校获得分子和细胞生物学学士学位和经济学学士学位,并在加州大学圣地亚哥分校获得医学学位。


Saumya Sutaria,was appointed Chairman of the Board in August 2023. He was appointed as the Company's Chief Executive Officer in September 2021, and as a member of the Board in November 2020.Prior to becoming Chief Executive Officer, he served as the Company's Chief Operating Officer from January 2019 to September 2021 and President from November 2019 to September 2021.Before joining the Company, Dr. Sutaria worked for McKinsey & Company, a global management consulting firm, for 18 years, most recently as a Senior Partner providing advisory support for hospitals, healthcare systems, physicians groups, ambulatory care models, integrated delivery, and government-led delivery, while also working with institutional investors in healthcare.He previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology.Dr. Sutaria received his Bachelor's Degree in molecular and cellular biology and his Bachelor's Degree in economics, both from the University of California, Berkeley, as well as his Medical Degree from the University of California, San Diego.
Saumya Sutaria于2019年1月被任命为公司首席运营官,于2019年11月被任命为总裁,并于2020年11月被任命为董事会成员。在加入公司之前,Sutaria博士在McKinsey&Company工作了18年,最近担任高级合伙人,为医院、医疗保健系统、医师团体、门诊护理模型、综合交付和政府主导的交付提供咨询支持,同时还与医疗保健的机构投资者合作。此前,他曾在加州大学旧金山分校(University of California at San Francisco)担任副临床教员,在那里他还从事以内科和心脏病学为重点的研究生培训。Sutaria博士在加州大学伯克利分校获得分子和细胞生物学学士学位和经济学学士学位,并在加州大学圣地亚哥分校获得医学学位。
Saumya Sutaria,was appointed Chairman of the Board in August 2023. He was appointed as the Company's Chief Executive Officer in September 2021, and as a member of the Board in November 2020.Prior to becoming Chief Executive Officer, he served as the Company's Chief Operating Officer from January 2019 to September 2021 and President from November 2019 to September 2021.Before joining the Company, Dr. Sutaria worked for McKinsey & Company, a global management consulting firm, for 18 years, most recently as a Senior Partner providing advisory support for hospitals, healthcare systems, physicians groups, ambulatory care models, integrated delivery, and government-led delivery, while also working with institutional investors in healthcare.He previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology.Dr. Sutaria received his Bachelor's Degree in molecular and cellular biology and his Bachelor's Degree in economics, both from the University of California, Berkeley, as well as his Medical Degree from the University of California, San Diego.
Paola M. Arbour

Paola M.Arbour于2018年5月被任命为Tenet’;的首席信息官,并于2019年3月被任命为执行副总裁。在这个职位上,Arbour女士负责监督Tenet’;的信息技术IT系统的领导和战略方向,并通过数字技术、数据和自动化的应用以及客户体验,确定支持该公司扩展的护理网络的机会。Arbour女士此前于2018年5月至2019年2月担任高级副总裁。加入Tenet之前,Arbour女士从2017年11月到2018年4月担任Prov International的总裁,从2016年7月到2017年9月担任ServiceNow的副总裁服务全球交付副总裁,从2010年12月到2016年4月担任Dell Services的服务交付。从1985年到2009年,Arbour女士在电子数据系统公司(Electronic Data Systems)的IT运营部门担任多个领导职务,包括公司总部以及伦敦和法兰克福。Arbour女士在密歇根州立大学获得了电信艺术和科学学士学位。


Paola M. Arbour,was appointed Tenet's Chief Information Officer in May 2018 and Executive Vice President in March 2019. In this capacity, Ms. Arbour oversees the leadership and strategic direction for Tenet's information technology (IT) systems and identifies opportunities to support the Company's expansive care network through the application of digital technology, data and automation, and customer experience. Ms. Arbour previously held the title of Senior Vice President from May 2018 to February 2019. Prior to Tenet, Ms. Arbour served as President at ProV International, a technology consulting firm, from November 2017 to April 2018, Vice President Services Global Delivery at ServiceNow, a software company, from July 2016 to September 2017, and as Vice President of Service Delivery at Dell Services from December 2010 to April 2016. From 1985 to 2009, Ms. Arbour held several leadership roles within IT operations at Electronic Data Systems – both at the company's headquarters and also in London and Frankfurt. In July 2021, Ms. Arbour was appointed to the board of directors of Texas Capital Bancshares, Inc. Ms. Arbour earned her bachelor's degree in telecommunications arts and sciences from Michigan State University.
Paola M.Arbour于2018年5月被任命为Tenet’;的首席信息官,并于2019年3月被任命为执行副总裁。在这个职位上,Arbour女士负责监督Tenet’;的信息技术IT系统的领导和战略方向,并通过数字技术、数据和自动化的应用以及客户体验,确定支持该公司扩展的护理网络的机会。Arbour女士此前于2018年5月至2019年2月担任高级副总裁。加入Tenet之前,Arbour女士从2017年11月到2018年4月担任Prov International的总裁,从2016年7月到2017年9月担任ServiceNow的副总裁服务全球交付副总裁,从2010年12月到2016年4月担任Dell Services的服务交付。从1985年到2009年,Arbour女士在电子数据系统公司(Electronic Data Systems)的IT运营部门担任多个领导职务,包括公司总部以及伦敦和法兰克福。Arbour女士在密歇根州立大学获得了电信艺术和科学学士学位。
Paola M. Arbour,was appointed Tenet's Chief Information Officer in May 2018 and Executive Vice President in March 2019. In this capacity, Ms. Arbour oversees the leadership and strategic direction for Tenet's information technology (IT) systems and identifies opportunities to support the Company's expansive care network through the application of digital technology, data and automation, and customer experience. Ms. Arbour previously held the title of Senior Vice President from May 2018 to February 2019. Prior to Tenet, Ms. Arbour served as President at ProV International, a technology consulting firm, from November 2017 to April 2018, Vice President Services Global Delivery at ServiceNow, a software company, from July 2016 to September 2017, and as Vice President of Service Delivery at Dell Services from December 2010 to April 2016. From 1985 to 2009, Ms. Arbour held several leadership roles within IT operations at Electronic Data Systems – both at the company's headquarters and also in London and Frankfurt. In July 2021, Ms. Arbour was appointed to the board of directors of Texas Capital Bancshares, Inc. Ms. Arbour earned her bachelor's degree in telecommunications arts and sciences from Michigan State University.
Thomas W. Arnst

Thomas W. Arnst,于2021年4月被任命为Tenet执行副总裁、首席行政官、总法律顾问和公司秘书。他以这一身份领导企业人力资源、法律和政府关系。他还担任首席风险官。在担任这些职务之前,Arnst先生曾担任Conifer子公司的首席行政官、总法律顾问和公司秘书。他在医疗保健、外包和金融服务等多个行业担任领导职务方面拥有超过30年的经验。在2018年加入Conifer之前,Arnst先生曾担任Millennium Health的首席行政官。此前的职位还包括Expert Global Solutions的执行副总裁、首席行政官、总法律顾问、全球人力资源主管和公司秘书。在其职业生涯中,阿恩斯特还曾在Safety-Kleen、AmeriServe、RailTex和Ryder担任过行政领导职务。他毕业于迈阿密大学,在那里他获得了法学博士学位和法学硕士学位。他在佛罗里达大西洋大学获得了金融领域的工商管理学士学位。


Thomas W. Arnst,was appointed Tenet's Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary in April 2021. In this capacity, he leads enterprise Human Resources, Legal and Government Relations. He also serves as Chief Risk Officer. Prior to assuming these roles, Mr. Arnst served as Chief Administrative Officer, General Counsel and Corporate Secretary of Conifer subsidiary. He has more than 30 years of experience working in leadership roles across healthcare, outsourcing and financial services, among other industries. Before joining Conifer in 2018, Mr. Arnst served as Chief Administrative Officer at Millennium Health. Previous positions also include Executive Vice President, Chief Administrative Officer, General Counsel, Head of Global Human Resources and Corporate Secretary at Expert Global Solutions. During his career, Mr. Arnst has also held executive leadership positions at Safety-Kleen, AmeriServe, RailTex and Ryder. He is a graduate of the University of Miami, where he received his Juris Doctor and his Master of Laws. He obtained his Bachelor of Business Administration degree in Finance from Florida Atlantic University.
Thomas W. Arnst,于2021年4月被任命为Tenet执行副总裁、首席行政官、总法律顾问和公司秘书。他以这一身份领导企业人力资源、法律和政府关系。他还担任首席风险官。在担任这些职务之前,Arnst先生曾担任Conifer子公司的首席行政官、总法律顾问和公司秘书。他在医疗保健、外包和金融服务等多个行业担任领导职务方面拥有超过30年的经验。在2018年加入Conifer之前,Arnst先生曾担任Millennium Health的首席行政官。此前的职位还包括Expert Global Solutions的执行副总裁、首席行政官、总法律顾问、全球人力资源主管和公司秘书。在其职业生涯中,阿恩斯特还曾在Safety-Kleen、AmeriServe、RailTex和Ryder担任过行政领导职务。他毕业于迈阿密大学,在那里他获得了法学博士学位和法学硕士学位。他在佛罗里达大西洋大学获得了金融领域的工商管理学士学位。
Thomas W. Arnst,was appointed Tenet's Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary in April 2021. In this capacity, he leads enterprise Human Resources, Legal and Government Relations. He also serves as Chief Risk Officer. Prior to assuming these roles, Mr. Arnst served as Chief Administrative Officer, General Counsel and Corporate Secretary of Conifer subsidiary. He has more than 30 years of experience working in leadership roles across healthcare, outsourcing and financial services, among other industries. Before joining Conifer in 2018, Mr. Arnst served as Chief Administrative Officer at Millennium Health. Previous positions also include Executive Vice President, Chief Administrative Officer, General Counsel, Head of Global Human Resources and Corporate Secretary at Expert Global Solutions. During his career, Mr. Arnst has also held executive leadership positions at Safety-Kleen, AmeriServe, RailTex and Ryder. He is a graduate of the University of Miami, where he received his Juris Doctor and his Master of Laws. He obtained his Bachelor of Business Administration degree in Finance from Florida Atlantic University.
Lisa Y. Foo

Lisa Y. Foo于2022年3月被任命为Tenet商业运营执行副总裁。在此职位上,Foo女士领导多项企业职能,包括战略、业务发展、营销、数据和分析以及采购。她此前曾于2019年4月至2022年3月担任副总裁、首席商务和战略官。在此之前,Foo女士曾在全球管理咨询公司麦肯锡公司担任多个职位,包括2017年至2019年在旧金山办事处担任副合伙人。她在麻省理工学院获得生物工程学理学学士学位。


Lisa Y. Foo,was appointed Tenet's Executive Vice President, Commercial Operations in March 2022. In this capacity, Ms. Foo leads several enterprise functions including strategy, business development, marketing, data and analytics, and procurement. She previously served as Vice President, Chief Commercial and Strategy Officer from April 2019 to March 2022. Prior to that, Ms. Foo held various positions at McKinsey & Company, a global management consulting firm, including Associate Partner from 2017 to 2019 in the San Francisco office. She earned her Bachelor of Science in Biological Engineering from Massachusetts Institute of Technology.
Lisa Y. Foo于2022年3月被任命为Tenet商业运营执行副总裁。在此职位上,Foo女士领导多项企业职能,包括战略、业务发展、营销、数据和分析以及采购。她此前曾于2019年4月至2022年3月担任副总裁、首席商务和战略官。在此之前,Foo女士曾在全球管理咨询公司麦肯锡公司担任多个职位,包括2017年至2019年在旧金山办事处担任副合伙人。她在麻省理工学院获得生物工程学理学学士学位。
Lisa Y. Foo,was appointed Tenet's Executive Vice President, Commercial Operations in March 2022. In this capacity, Ms. Foo leads several enterprise functions including strategy, business development, marketing, data and analytics, and procurement. She previously served as Vice President, Chief Commercial and Strategy Officer from April 2019 to March 2022. Prior to that, Ms. Foo held various positions at McKinsey & Company, a global management consulting firm, including Associate Partner from 2017 to 2019 in the San Francisco office. She earned her Bachelor of Science in Biological Engineering from Massachusetts Institute of Technology.